
Giuseppe Lopalco
@giuseppelopalc2
Associate Professor in #Rheumatology at @unibait | Member of @official_ASAS and AIDA Network | Editor for @ojrarediseases and @Frontimmunol
ID: 1436680419613810693
https://pubmed.ncbi.nlm.nih.gov/?term=Lopalco+g&sort=date 11-09-2021 13:18:12
240 Tweet
477 Followers
449 Following

π’ New study on Secukinumab in PsA! π₯ from GISEA πΉ 63.2% drug survival at 24 months πΉ Improved disease activity (DAPSA, PASI, ASDAS-CRP) π πΉ Higher persistence in mixed PsA (peripheral+axial) πΉ Well-tolerated, no serious AEs! πβ Sage Journals π doi.org/10.1177/175972β¦